Expression of Epidermal Keratins and the Cornified Envelope Protein Involucrin is Influenced by Permeability Barrier Disruption  by Ekanayake-Mudiyanselage, Swarna et al.
Expression of Epidermal Keratins and the Cornified Envelope
Protein Involucrin is Influenced by Permeability Barrier
Disruption
Swarna Ekanayake-Mudiyanselage, Heinrich Aschauer,* Fritz P. Schmook,* Jens-Michael Jensen,
Josef G. Meingassner,* and Ehrhardt Proksch
Department of Dermatology, University of Kiel, Germany; *Department of Chemistry and Pharmacology, Novartis Research Institute, Vienna, Austria
In previous studies we have shown that experimental
permeability barrier disruption leads to an increase in
epidermal lipid and DNA synthesis. Here we investigate
whether barrier disruption also influences keratins and
cornified envelope proteins as major structural keratino-
cyte proteins. Cutaneous barrier disruption was achieved
in hairless mouse skin by treatments with acetone K
occlusion, sodium dodecyl sulfate, or tape-stripping. As
a chronic model for barrier disruption, we used essential
fatty acid deficient mice. Epidermal keratins were deter-
mined by one- and two-dimensional gel electrophoresis,
immunoblots, and anti-keratin antibodies in biopsy
samples. In addition, the expression of the cornified
envelope proteins loricrin and involucrin after barrier
disruption was determined by specific antibodies in
human skin. Acute as well as chronic barrier disruption
resulted in the induction of the expression of keratins K6,
K16, and K17. Occlusion after acute disruption led to
The permeability barrier of the skin is localized in thestratum corneum and consists of protein-enrichedcorneocytes and lipid-enriched intercellular domains(Elias, 1983). The barrier is formed during terminaldifferentiation of the epidermis that results in corneocytes
comprising an insoluble cornified envelope and cross-linked cytoskeletal
proteins (Downing, 1992; Roop, 1995). The lipids for barrier function
are synthesized in the keratinocytes of the nucleated epidermal layers,
stored in the lamellar bodies, and extruded into the intercellular spaces
during the transition from the stratum granulosum to the stratum
corneum forming a system of continuous membrane bilayers (Elias,
1983; Menon et al, 1992). Several studies in hairless mouse skin have
shown that barrier disruption leads to an increase in epidermal lipids
synthesis including cholesterol, free fatty acids, and ceramides (Grubauer
et al, 1987, 1989; Holleran et al, 1991). Also, we have shown that
barrier disruption in acute [topical treatments by acetone, 10% sodium
dodecyl sulfate (SDS), or by tape-stripping] and chronic models
[essential fatty acid deficient diet (EFAD)] leads to an increase in DNA
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a slight reduction of keratin K6 and K16 expression.
Expression of basal keratins K5 and K14 was reduced
after both methods of barrier disruption. Suprabasal
keratin K10 expression was increased after acute barrier
disruption and K1 as well as K10 expression was increased
after chronic barrier disruption. Loricrin expression in
mouse and in human skin was unchanged after barrier
disruption. In contrast, involucrin expression, which was
restricted to the granular and upper spinous layers in
normal human skin, showed an extension to the lower
spinous layers 24 h after acetone treatment. In summary,
our results document that acute or chronic barrier disrup-
tion leads to expression of keratins K6, K16, and K17 and
to a premature expression of involucrin. We suggest that
the coordinated regulation of lipid, DNA, keratin, and
involucrin synthesis is critical for epidermal permeability
barrier function. Key word: loricrin. J Invest Dermatol
111:517–523, 1998
synthesis resulting in epidermal hyperproliferation (Proksch et al, 1991,
1992). Bulk protein synthesis is not increased after barrier disruption
(Choi et al, 1992), but a variety of specific proteins, e.g. actin, LDL-
Receptor, or enzyme proteins, are upregulated after acute barrier
disruption (Jackson et al, 1992).
The purpose of our studies was to examine whether major structural
proteins synthesized in the keratinocytes are influenced by permeability
barrier function. The commonly used phenotypic markers of epithelial
development and differentiation are keratins. They emanate from a
perinuclear ring (free ribosomes), extend throughout the cytoplasm,
and terminate at desmosomes and hemidesmosomes (Roop, 1995).
During epidermal differentiation specific keratins are synthesized.
Keratins 5 and 14 (K5 and K14) are expressed in basal keratinocytes,
K1 and K10 in differentiating suprabasal keratinocytes, and K6 and
K16 in suprabasal layers of psoriasis and in wound healing (Thewes
et al, 1991; Wilson et al, 1992; Hagemann and Proksch, 1996; Paladini
et al, 1996). K17 has been observed in suprabasal layers in interfollicular
psoriatic skin (Jiang et al, 1993; Smack et al, 1994; McKay and Leigh,
1995; Fuchs, 1995; Leigh et al, 1995). Mutations in keratin genes
can result in human diseases characterized by a disturbed epidermal
homeostasis including a disturbed barrier function (Roop, 1995; Frost
et al, 1968; Cheng et al, 1992; Chipev et al, 1992; Lane et al, 1992;
Rothnagel et al, 1992).
The cornified envelope is a specialized structure that replaces the
plasma membrane of terminally differentiating keratinocytes, it consists
of proteins cross-linked by covalent bonds into a rigid scaffold, with
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lipids (hydroxyceramides) covalently attached to its external surface
and the filament-matrix complex (keratins) interacting with its internal
surface (Ming et al, 1994; Roop, 1995; Steinert and Marekov, 1995,
1997). Involucrin is a cytoplasmatic protein synthesized by human
squamous epithelial cells; it is expressed early in the keratinocyte
differentiation process and is a major early isopeptide cross-linked
component of the keratinocyte cornified cell envelope (Rice and
Green, 1979; Kanitakis et al, 1987; Robinson et al, 1996; Steinert et al,
1997). Involucrin can be detected in the cell periphery of high stratum
spinosum cells by using specific antibodies. In hyperproliferative diseases
like psoriasis, premature expression of involucrin is found in the lower
spinous layers (Kanitakis et al, 1987; Hohl, 1990; McKay et al, 1995).
Recently, Marekow et al provided evidence that covalently bound
lipids are linked to involucrin.1 Loricrin, also a cornified envelope
protein, is expressed very late in epidermal differentiation in the
granular layers of normal mouse and human epidermis. Loricrin
initially accumulates in keratohyaline granules, termed L-granules.
Subsequently, loricrin becomes cross-linked as a major component of
the cornified envelope (Hohl, 1990; Steinert et al, 1995). A coordinated
expression of loricrin with other epidermal proteins and the appearance
of lipid lamellar granules in mouse gestational development has been
reported (Bickenbach et al, 1995).
We examined in acute and chronic models whether artificial per-
meability barrier disruption leads to changes in epidermal proliferation-
and differentiation-related keratins and to changes in the cornified
envelope proteins loricrin and involucrin. We found pronounced
changes in these structural keratinocyte proteins after permeability
barrier disruption.
MATERIALS AND METHODS
Animals Female hairless mice [Crl:(hr/hr) BR] aged of 3 or 6–8 wk were
supplied by Charles River (Sulzfeld, Germany). The animals were maintained
conventionally under standardized conditions (room temperature, 22 6 1°C;
relative humidity, 55 6 5%; 10 air changes per h; 12 h day/12 h night cycle)
in groups in plastic cages with polyester filter covers on wood granulate bedding.
The 3 wk old animals were fed either with standard laboratory animal chow
or with an EFAD diet (Bavandi et al, 1992), modified by increasing MgSO47H2O
to 2.38 g per kg. Food and water was supplied ad lib.
Experimental protocol Acute disruption of the permeability barrier was
induced by absolute acetone, by 10% SDS (in water) (treatments for 2–5 min
with acetone- or SDS-soaked cotton swabs, respectively), or by tape-stripping
(cellophane tape, Scotch type, six to eight times) until a 20–30-fold increase
in transcutaneous/transepidermal water loss (TEWL) was achieved (Meeco
electronic water analyzer, Meeco, Warrington, PA). Occlusion after barrier
disruption was achieved by immediately inserting the mouse into a thumb of
powderless latex gloves for 24 h as described previously (Grubauer et al, 1987).
For each experiment at least three animals were treated and at least three
animals served as control. At different points of time after treatment (3–72 h),
skin samples of ~1 cm2 from groups of 3–5 mice were obtained. Chronic
barrier disruption in mice was achieved by maintenance with EFAD diet up to
18 wk. Skin samples were collected from three mice sacrificed after 3, 6, 9,
12, 15, and 18 wk on EFAD diet. Occlusion in EFAD mice was performed for
3 d in week 12. TEWL as a marker of barrier function was measured in these
animals with an Evaporimeter (EP1, Servo Med, Kinna, Sweden). In human
skin of three volunteers, barrier disruption was achieved by treatments with
acetone-soaked cotton swabs for 15–30 min until a 4–6-fold increase in TEWL
was achieved; at 12 h, 24 h, and 48 h, 4 mm punch biopsies were obtained.
The study protocols were approved by the University of Kiel, by the Human
Research Review Committee, and by the Committee of Animal Care,
respectively.
Murine epidermal proliferation assay in vivo One hour before skin
dissection 30 mg bromodesoxyuridine per kg (BrdU, # RPN 201, Amersham)
were injected intraperitoneally. Five micrometer skin sections (prepared as
described above) were processed by standard immunohistologic peroxidase
technique using a monoclonal anti-BrdU-antibody (#RPN 201, Amersham)
and diaminobenzidine as substrate as recommended by the supplier of the
1Marekov LN, Steinert PM: Evidence that the lipids of the epidermal
cornified cell envelope are attached directly to involucrin. J Invest Dermatol
106:828A, 1996 (abstr.)
staining kit. The stained sections (one per mouse) were examined microscopically
(1603) by counting the BrdU-labeled nuclei of interfollicular keratinocytes
(cells in S-phase) in seven microscopic fields/sections. Labeling index in mice
on an EFAD diet and in age-matched normally fed animals was defined by
numbers of BrdU1 cells per mm epidermal basal membrane. Morphometry
was performed with an image analyzer (Videoplan, Kontron, Munich, Germany).
Determination of epidermal keratins and cornified envelope proteins
One-dimensional gel electrophoresis From full-thickness murine skin samples, the
epidermis was removed by heat treatment (60°C, 3 min) and washed with 10 mM
phosphate/147 mM saline/5 mM bis-(aminoethyl)-glycolether-N,N,N9,N9-
tetraacetic acid (pH 7.4) and then homogenized (glass homogenizers) in 20 mM
TRIS-HCI (pH 7.4), containing 1 Mm phenylmethylsulfonyl fluoride and 5 µg
per ml each of pepstatin and antipain. The homogenate was extracted five
times with 600 mM KCl/5 mM bis-(aminoethyl)-glycolether-N,N,N9,N9-
tetraacetic acid/5 mM ethylene diamine N,N,N9,N9-tetraacetic acid disodium
salt/1% Triton X-100/50 mM TRIS/Hcl [Tris-(hydroxymethyl)aminomethane]
pH 7.4 and protease inhibitors as described (Wild and Mischke, 1986), with
sonication (10 min) and subsequent centrifugation (5 min, 15,0003g). The
resulting pellet was solubilized in sample buffer (2% SDS/5% mercaptoethanol/
10% glycerol/0.001%bromophenol blue/62.5 Mm TRIS-Hcl pH 6.8) and
heated to 95°C for 10 min as required for electrophoresis (Laemmli, 1970).
Sodium dodecylsulfate-polyacrylamide gel electrophoresis (SDS-PAGE) was
performed at limiting 600 V, 50 Ma, and 30 W with a Macrodrive power
supply and a Multiphor II electrophoresis chamber for µ1.5 h using 12.5%
homogenous Excel Gels SDS and SDS buffer strips (all Pharmacia, Freiburg,
Germany). Molecular weight markers from Novex (Mark 12) and Amersham
(Rainbow Marker, Buckinghamshire, U.K.) were run in parallel. For Coomassie
staining 20 µg, and for blotting/immunostaining 4 µg of the initial epidermis
sample was applied to the gel. Fixing, Coomassie staining, destaining, and
preserving of gels was performed as outlined by the manufacturer (Pharmacia).
Dried gels were scanned and the images analyzed (not shown) and calculated
(integrated) with a ImageMaster 1D Elite System (Pharmacia).
Two-dimensional gel electrophoresis For two-dimensional gel electrophoresis,
epidermis and dermis were separated by heating to 60°C (3 min for murine
skin, 5 min for human skin) in phosphate buffered saline. The epidermis was
disrupted in a glass homogenizer with a high-salt buffer containing 1.5 M KCl,
10 mM NaCl, 0.5% Triton X-100, 2 mM dithioerythritol, and 10 mM Tris-
HCl (pH 8.0), homogenized, and centrifuged at room temperature for 10 min
(12,000 3 g, four times). The final pellet was incubated with 20 µl GTC-
buffer [4 M guanidinium thiocyanate, 0.1 mM Tris-HCl (pH 7.5), 1%
mercaptoethanol] and homogenized at 65°C for 40 min. After centrifugation
for 10 min (12,000 3 g, 18°C) the supernatant was subjected to two-dimensional
gel electrophoresis. The extracted keratins were analyzed by two-dimensional
gel electrophoresis, using equilibrium isoelectric focusing or nonequilibrium
pH gradient gel electrophoresis in the first dimension and SDS-PAGE with 9%
acrylamide in the second dimension (O’Farell et al, 1977). Gels were stained
with Coomassie brilliant blue R-250. The keratins were identified by comparing
the results with published data (Moll, 1993; Schweizer, 1993; Zouboulis et al,
1993; Yoshikawa et al, 1995) and by immunoblotting using specific antibodies.
Immunostaining of keratin 6, involucrin, and loricrin in skin
sections Murine skin samples were fixed in formalin and embedded in
paraffin. After deparaffination and rehydration, 5 µm thick sections were
incubated with 3% H2O2 for 5 min to block endogenous peroxidase activity
and the rinsed sections exposed to 5 3 5 min microwave irradiation (650 W)
for antigen detection according to Hazelbag et al (1995). After blocking
nonspecific antibody binding by incubation with 20% normal pig serum (DAKO
A/S, Denmark, 20 min, room temperature), the primary antibodies [anti-K6,
1:800, anti-loricin 1:500 or anti-involucrin (undiluted, Biomedical Technolo-
gies, Stoughton, MA; German distributor: Paesel & Lorei, Frankfurt, Germany)]
were applied for 30 min at room temperature (Rosenthal et al, 1992; Hohl
et al, 1993). A strep AB complex/HRP (DAKO A/S, 1:100, 30 min, room
temperature) was used as a third antibody, followed by incubation with
diaminobenzidine as peroxidase substrate.
Immunoblot analysis Two methods were used for one- and two-dimen-
sional gel electrophoresis, respectively. (i) After blocking of the nonspecific
binding sites with 3% gelatine in Tris-buffered saline the following staining
protocol was used: as primary antibody, the monoclonal mouse anti-keratin
antibodies CK 8.12 (Biomakor, Rehovot, Israel) and LLO25 were used for 3 h
at room temperature, diluted 1:500 (CK 8.12) or 1:100 (LLO25) with 1%
gelatine/0.01% NaN3. After two washings with Tris-buffered saline with 0.05%
Tween 20/L a 1:1000 diluted peroxidase conjugated goat anti-mouse IgG
(H 1 L) antibody (Biorad, Richmond, CA) was used for 1 h as secondary
antibody. After two further washings with Tris-buffered saline with 0.05%
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Figure 1. Immunostaining of keratin K6 after acetone-induced barrier disruption. (A) Normal mouse skin; (B) 12 h after barrier disruption; (C) 24 h
after barrier disruption; (D) 24 h after barrier disruption 1 occlusion. Biopsies were sectioned and stained with K6 specific antibody. Scale bar: 15 µm.
Tween 20/L the bands were developed by addition of HRP-color development
solution (4-chloro-1-naphthol/methanol/Tris-buffered saline/hydrogen per-
oxide). (ii) A horizontal semidry electroblotter with 0.2 µm nitrocellulose
membrane, GB002 blotting paper (both from Schleicher & Schuell, Germany)
was used with 0.048 M Tris, 0.039 M glycine, 20% methanol (pH 9.2) as
transfer buffer. The blotting time was 2 h at 0.2 mA per cm2, 100 V. Blocking
was achieved with a mixture of 5% skim milk and 2% Tween 20 for µ10 min.
As primary antibody, 1:2000 diluted CK 8.12 (Sigma, St. Louis, MO) was used
overnight and washed with 0.05 M Tris-Hcl, 0.5 M NaCl, 0.1% vol/vol
Tween-20 (pH 9.0). As secondary antibody a rabbit anti-mouse peroxidase
linked antibody (Sigma, 1:1000) was used for 3 h. For staining, 0.02%
diaminobenzidine in a citrate/phosphate-buffer [0.035 M citric acid, 30% H2O2,
0.067 M Na2HPO4 (pH 5.0)] was used.
RESULTS
Permeability barrier disruption influences hyperproliferation-
associated keratins K6, K16, and K17 In untreated hairless mouse
epidermis as well as 3 h and 6 h after acetone-induced barrier disruption,
we found no changes in the keratin expression either by immunostaining
or by one- and two-dimensional gel electrophoresis. Keratin K6, K16,
and K17 expression was first detected at 12 h after acute barrier
disruption. The K6 antibody showed staining of basal and lower
spinous layers (Fig 1). By two-dimensional gel electrophoresis we
found small spots for keratins K16 and K17 at this time point
(data not shown). Twenty-four hours after barrier disruption K6
immunostaining was noted in all nucleated epidermal layers (Fig 1),
K16 was detected by one-dimensional gel electrophoresis (Fig 2,
Table I), and K6, K16, and K17 were identified by two-dimensional
gel electrophoresis. K6 was most visible by nonequilibrium pH gradient
electrophoresis. K16 and K17 were clearly visible by equilibrium
isoelectric focusing (Fig 3). Distinct expression for K6, K16, and K17
by immunostaining and by two-dimensional gel electrophoresis was
also noted at 48 h and 72 h after barrier disruption.
In addition to acetone treatment we performed permeability barrier
disruption by treatments with a detergent (SDS) and by tape-stripping
to show that changes are not dependent on method, but are common
to a variety of unrelated forms of disruption. After SDS or tape-
stripping induced barrier disruption we also found the expression of
keratins K6, K16, and K17 (examined only at 24 h after treatment)
(data not shown). Occlusion for 24 h after acetone-induced barrier
disruption led to a moderate focal reduction in K6 immunostaining
(Fig 1) and to a slight decrease in K16 expression by one- and two-
dimensional gel electrophoresis (Fig 2, Table I).
Figure 2. Keratins K1, K5, and K16 are influenced by acetone
treatment K occlusion and by EFAD K occlusion (one-dimensional
electrophoresis). Lane a, normal mouse skin; lane b, 24 h after acetone
treatment; lane c, 24 h after acetone treatment 1 occlusion; lane d, EFAD (12th
week); lane e, EFAD 1 occlusion (for 3 d). Keratins were purified by a standard
cytoskeletal method and analyzed by SDS-PAGE.
The pattern of hyperproliferation-associated keratins in EFAD mice
was similar to acetone-induced barrier disruption, and keratins K6,
K16, and K17 were expressed (Figs 2, 3, Table I). These changes in
keratin staining pattern first occurred 6 wk after commencement of
feeding an EFAD diet and increased while on a diet in weeks 9–12,
in parallel with the ongoing defect of barrier function (TEWL:
untreated, 8.7 6 0.2 g per h per m2; 9th week, 41.9 6 9.2* g per h
per m2; 12th week, 67.3 6 8.7* g per h per m2; *p , 0.01, n 5 3–
9). In EFAD replete mice, after changing to a normal diet, TEWL and
keratin pattern normalized within 2 wk.2 Occlusion for 3 d in EFAD
mice (12 wk on diet) led to a further increase in TEWL (Proksch et al,
1992), in contrast epidermal proliferation was reduced. BrdU labeling
was 5-fold increased in EFAD (38.3 6 6.15 BrdU1-keratinocytes per
mm epidermal basal membrane, 12th week) compared with normal
2Schmook FP, Pecanka R, Kowalsky E, Meingassner JG: Diet-induced
changes in epidermal keratins in mice. J Invest Dermatol 105:495A, 1995 (abstr.)
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Table I. Band intensities (peak areas) of keratins after acute or chronic barrier disruption 6 occlusion (one-dimensional
electrophoresis, Fig 2)a
Band (keratin) Lane A Lane B Lane C Lane D Lane E
(untreated) % (acetone) % (acetone 1 occlusion) % (EFAD) % (EFAD 1 occlusion) %
1 (K1) 16.71 6.97 9.12 23.45 18.15
3 (K5) 27.84 15.71 14.59 15.46 12.95
4 (K10) 30.40 37.45 38.37 35.85 39.93
5 (K14) 25.05 20.81 20.87 18.12 20.02
6 (K16) 0 19.07 17.05 7.12 8.94
aDried gels were scanned, image analyzed (not shown), and calculated (integrated) by a ImageMaster 1D Elite System (band intensities in percentage of the total intensity of keratin peaks).
(8.01 6 3.83, p , 0.01, n 5 5). Occlusion in EFAD mice led to a
64% reduction in epidermal proliferation compared with unoccluded
mice; however, this was still above normal (13.6 6 4.84, p , 0.025,
n 5 5). Keratin K6, K16, and K17 expression was not significantly
reduced by occlusion in EFAD (Fig 2, Table I).
Permeability barrier disruption influences basal (K5 and K14)
and suprabasal (K1 and K10) keratins One-dimensional gel
electrophoresis of keratins from the epidermis of untreated hairless
mice showed four prominent keratin bands (1, K1; 3, K5; 4, K10;
5, K14). Twenty-four hours after experimental permeability barrier
disruption by acetone the expression of the basal keratins K5 and K14
as well as expression of the suprabasal keratin K1 was reduced compared
with normal. In contrast, the relative amount of suprabasal keratin K10
was increased. After chronic barrier disruption by EFAD, the expression
to basal keratins K5 and K14 was reduced. In contrast, expression of
suprabasal keratins K1 and K10 was increased compared with untreated
epidermis. Occlusion after acute and chronic barrier disruption did not
significantly influence the expression of basal or suprabasal keratins
(Fig 2, Table I).
Permeability barrier disruption did not influence the expression
of the cornified envelope protein loricrin in hairless mouse
skin Loricrin immunostaining in untreated mouse skin was confined
to the granular layers. Twelve, 24, and 48 h after barrier disruption,
loricrin immunostaining was unchanged (data not shown). Neither
barrier disruption by acetone, nor barrier disruption by SDS or by
tape-stripping influenced loricrin expression in mouse skin. (We were
unable to examine involucrin expression in mice, because there is no
antibody available that works in skin sections of the mouse system.)
Permeability barrier disruption influences the expression of the
cornified envelope protein involucrin but not loricrin in human
skin In human skin, as in mouse skin, loricrin immunostaining was
confined to the granular layers and did not change after experimental
permeability barrier disruption (data not shown). Involucrin staining
in untreated human skin as well as 6 h and 12 h after barrier disruption
was confined to the granular and uppermost spinous layers. Changes
in involucrin expression occurred 24 h and 48 h after treatment;
staining was more pronounced and was extended to the middle spinous
layers. After occlusion for 24 h there was a further extension of
involucrin staining to the lower spinous layers (Fig 4).
DISCUSSION
We have shown that acute as well as chronic disruption of the epidermal
permeability barrier results in changes in major structural proteins
synthesized in the keratinocyte and related to proliferation and differen-
tiation. Expression of the hyperproliferation-associated keratins K6,
K16, and K17 determined by three different methods, was induced by
acute barrier disruption. Similar expression of keratins has been
described in human diseases that are accompanied by a disturbed
permeability barrier. K16 is expressed in allergic and irritant contact
dermatitis (acute or chronic disease) (Le et al, 1995) and K17 is
expressed in a delayed type hypersensitivity induced by a mumps
vaccine in human skin (Jiang et al, 1993). Also, K6, K16, and variable
amounts of K17 are expressed in the hyperproliferative epidermis of
psoriasis (a chronic disease) (Thewes et al, 1991; Moll, 1993; Smack
et al, 1994); however, expression of these keratins is not necessarily
linked to hyperproliferation. Kopan and Fuchs showed that the
reduction in K6/K16 in retinoid-treated SCC-13 cultures was not
accompanied by a decrease in cell proliferation (Kopan and Fuchs,
1989). In our study we were also interested in the time curve of the
induction of keratins after acute permeability barrier disruption. K6,
K16, and K17 were expressed as early as 12 h after acetone treatment
and preceded epidermal hyperproliferation [we previously showed that
an increase in DNA synthesis occurs 18–20 h after barrier disruption
(Proksch et al, 1991)]. This also shows that the expression of these
keratins is not a consequence of epidermal hyperproliferation. A similar
time curve for the expression of K6 and K16 in healing of wounded
human skin has been found previously and correlates with the onset
of re-epithelization and a reorganization of keratin filaments in normal
edge keratinocytes (Mansbridge and Knapp, 1987; Paladini et al, 1996).
This reorganization of keratin filaments probably also occurs after
permeability barrier disruption.
The relationship between permeability barrier function and keratin
expression is also shown by our chronic EFAD model. In EFAD,
barrier disruption occurs as a result of a metabolic disturbance. In these
mice the lipid organization in the stratum corneum bilayers is disturbed
because linoleic acid is replaced by oleic acid in ceramide 1 (Wertz
et al, 1987; Hou et al, 1991). EFAD mice showed an increase in
TEWL, but also an increase in lipid and DNA synthesis (Proksch et al,
1992). We then found that keratins K6, K16, and K17 are induced in
EFAD. Staining of keratins changed with time during the EFAD diet,
in parallel with the ongoing chronic permeability barrier disruption
(increase in TEWL).
Occlusion after acetone treatment led to a slight decrease in the
expression of the hyperproliferation-associated keratins K6 and K16,
but did not influence K17. Previous studies have shown that the
acetone-induced increase in lipid synthesis could be prevented by
occlusion (Grubauer et al, 1987); however, in previous studies and in
this study we also showed that the increase in epidermal proliferation
induced by acute and chronic barrier disruption is only partially
prevented by occlusion. DNA synthesis after acetone 1 occlusion or
EFAD 1 occlusion is significantly reduced compared with unoccluded
skin, but is still well above normal (Proksch et al, 1991). The small
effect of occlusion on keratin expression after acute barrier disruption
and the lack of effects after chronic barrier disruption also show that
there is not necessarily a link between hyperproliferation and K6, K16,
and K17 expression.
Basal and suprabasal keratins were also influenced by barrier disrup-
tion. In the acute model, expression of keratins K5 and K14 was
decreased. Also, we noted a decrease in suprabasal keratin K1, con-
trasting with an increase in keratin K10. Decrease of the suprabasal
differentiation-associated keratin K1 could be related to a disturbed
differentiation after barrier disruption (Thewes et al, 1991). The small
decrease in K14 was only noted because of the additional expression
of K16. In EFAD mice, basal keratins K1 and K5 were reduced, and
suprabasal keratins K1 and K10 were increased. This correlates with
the increased thickness of the epidermis in EFAD (increase in the
suprabasal compartment). The increase in suprabasal differentiation-
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Figure 3. Keratins K16 and K17 are expressed after acetone- and EFAD-
induced barrier disruption. (A) Normal mouse skin; (B) 24 h after acetone
induced barrier disruption; and (C) EFAD mice. Keratins were extracted by a
standard cytoskeletal method, separated initially by isoelectric focusing
(pH 4–8), and then in the second dimension by SDS-PAGE.
associated keratins could be an attempt to repair the permeability
barrier despite ongoing EFAD.
Surprisingly, different effects of barrier disruption on the expression
of the two cornified envelope proteins involucrin and loricrin after
barrier disruption was noted. Twenty-four hours after barrier disruption
in human skin we found an extension of the involucrin expression
from the granular layers and the upper spinous to the lower spinous
layers (antibodies suitable for the mouse system were not available).
This is in accordance with the results in diseased skin accompanied by
a disturbed epidermal permeability barrier. In eczematous skin as well
Figure 4. Premature immunostaining of involucrin after permeability
barrier disruption. (A) Normal human skin; (B) 24 h after acetone-induced
barrier disruption; (C) 24 h after barrier disruption 1 occlusion. Biopsies were
sectioned and stained with an involucrin specific antibody. Scale bar: 15 µm.
as in psoriasis an extension of involucrin expression to lower spinous
layers has been reported (Hohl, 1990; Rosenthal et al, 1992; McKay
et al, 1995; Proksch and Hagemann, 1996). Involucrin is a cytoplasmatic
protein expressed early in keratinocyte differentiation and an early
component of the cornified envelope (Robinson et al, 1996; Steinert
et al, 1997). Loricrin expression, at the time points examined (12 h to
48 h after treatment), was unchanged after barrier disruption in mouse
skin as well as in human skin. In eczema and psoriasis an unchanged
or slightly reduced staining of loricrin has been noted (Hohl, 1993).
Loricrin is expressed very late in epidermal differentiation and becomes
cross-linked as a major component of the cornified envelope (Hohl,
1990; Steinert et al, 1995). It has previously been reported from cell
culture studies involving retinoids that involucrin and loricrin synthesis
are regulated by different mechanisms (Hohl et al, 1993).
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Occlusion after acute barrier disruption in human skin did not
reduce the expression of involucrin. As mentioned earlier, it was shown
in mouse skin that occlusion reduced an acetone-induced increase in
lipid synthesis and the increase in its rate-limiting enzymes towards
normal (Grubauer et al, 1987; Proksch et al, 1990; Holleran et al, 1991;
Ottey et al, 1995). For the determination of the lipid synthesis,
occlusion after barrier disruption was performed for only 2–4 h, because
the increase occurs rapidly. For involucrin expression we occluded for
24 h, because we found changes in involucrin expression without
occlusion at that time point. It is difficult to obtain tightly fitting
occlusion in human skin for such a long time period. Also, the effect
of occlusion on epidermal proliferation is less pronounced in human
than in mouse skin (Proksch et al, 1996). After irritation in human
skin (SDS patch test application for 24 h, which also leads to barrier
disruption) a reduction in epidermal proliferation by occlusion was not
found at all (Welzel et al, 1996).
A link between keratins and barrier function is known in the human
disease epidermolytic hyperkeratosis (also known as bullous congenital
ichthyosiform erythroderma Broque), in which mutations of either
keratin K1 or K10 have been identified as the underlying defect
(Cheng et al, 1992; Chipev et al, 1992; Rothnagel et al, 1992). The
epidermal permeability barrier is disturbed in this disease as has been
shown previously by an increased TEWL (Frost et al, 1968). Interactions
between keratins, cornified envelope proteins, and covalently bound
lipids has been described by several authors (Hohl, 1990; Downing,
1992; Bickenbach et al, 1995; Steinert et al, 1995). Also, there is
evidence that keratins are linked to the cornified envelope protein
involucrin (Steinert et al, 1997). We now suggest that these interactions
are influenced by skin barrier function.
Our findings clearly document that experimental permeability barrier
disruption in acute and chronic models influences keratin polypeptides
and the cornified envelope protein involucrin. The coordinated regula-
tion of lipid synthesis, epidermal proliferation, and epidermal differenti-
ation is critical for skin barrier function.
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